Clinical Trial

Jafron Cytokine Adsorber During Pediatric Open-Heart Surgeries

Study acronym: JACKPOT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This prospective single-center randomized controlled trial aims at evaluating the safety and feasibility of an hemoadsorption protocol using Jafron HA-60 during cardio-pulmonary bypass in 20 pediatric patients undergoing open-heart surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-30.
Trial Details
NCT Number NCT07393087
Lead Sponsor Centre Hospitalier Universitaire Vaudois
Conditions Cardiac Surgery Recovery, Inflammation, Complex Cardiovascular Surgery With Cardiopulmonary Bypass, Cytokine Storm, Pediatric Open Heart Surgery
Enrollment 20 participants
Start Date 2026-03
Primary Completion 2029-03 (estimated)
Study Completion 2029-04 (estimated)
Updated on ClinicalTrials.gov 2026-02-10